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Background: AIDS patients are at increased risk of developing concurrent infections
with viral, parasitic, fungal or mycobacterial organisms. They can present constitu-
tional symptoms of fever and weight loss, either due to infections or an underlying
lymphoma which may coexist.
Case report: A child with HIV-AIDS and mild encephalopathy is reported, who during
the course of a confirmed disseminatedmycobacterial disease developed neurological
impairment. Post-mortem examination revealed disseminated BCG infection and
Epstein-Barr associated primary CNS lymphoma. Epstein-Barr virus (EBV) presence
was assessed by LMP-1 protein labelling by immunohistochemistry and in situ hybri-
disation (ISH) for Epstein-Barr virus-encoded RNAs (EBERs) in formalin-fixed and
paraffin-embedded sections.
Conclusions: BCG vaccination among HIV-1 infected children leads to the risk of
disseminated BCG infection. BCG immunization programmes should be reconsidered
for children at risk of HIV infection, because the risk of delayed complications is
independent of the immunological status at the time of the vaccination.1 4553 5903; fax: +54 11
net.ar (A. Fallo).
al Society for Infectious Diseases. Published by Elsevier Ltd. All rights reserved.
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Only isolated cases of primary CNS lymphoma occurring in HIV-infected children
have been reported, and a striking association with EBV infection has been demon-
strated.
# 2004 International Society for Infectious Diseases. Published by Elsevier Ltd. All
rights reserved.Introduction
Human immunodeficiency virus infection produces a
broad spectrum of diseases in both children and
adults. AIDS patients are at increased risk of devel-
oping opportunistic infections. Patients may present
symptoms of fever and weight loss, either due to
infections or a coexisting lymphoma. In children,
opportunistic, reactivated latent infection and CNS
lymphoma have been infrequent according to neu-
roradiological and autopsy examination. The most
frequent CNS complication is progressive encepha-
lopathy attributable to primary HIV infection of the
brain.1
Primary CNS lymphoma represents a frequent
complication of HIV infection in adults, occurring
in as many as 6—10% of patients with AIDS, however,
only isolated cases of primary CNS lymphoma occur-
ring in HIV-infected children have been reported,2—5
and a striking association with Epstein-Barr virus
(EBV) infection has been demonstrated.5—7
Disseminated infection by bacillus Calmette-
Gue´rin (BCG) is a rare but severe complication of
BCG vaccination in immunodeficient patients. There
is an increasing number of reports on this topic.
Local or disseminated BCG disease has historically
been a disease of infants, but cases in adults and
older children with AIDS have been reported.8,9
A case is reported here of a child with AIDS with a
mild HIV encephalopathy, who during the course of
confirmed disseminated mycobacterial disease
developed neurological impairment. Post-mortem
examination revealed disseminated BCG infection
and Epstein-Barr virus associated primary CNS lym-
phoma.Material and methods
Immunohistochemistry (IHC)
The detection of latent membrane protein-1 (LMP-1)
of EBV was performed using a pool of four mono-
clonal antibodies (MoAbs) CS1-4 (Dako Corporation,
Carpinteria, CA, USA). Immunohistochemical char-
acterization of the lymphoma was performed using
antibodies to CD20 (L26), CD3 (PS1) (BioGenex, San
Ramon, CA, USA) CD30 (Ber-H2), CD15 (Leu-M1) and
CD68 (PG-M1) (Dako Corporation, Carpinteria, CA,USA). Immunohistochemical detection on formalin
fixed paraffin embedded tissues employed the
streptavidin-biotin complex with horseradish perox-
idase technique according to the manufacturer’s
instructions (Dako Corporation, CA, USA).
In situ hybridization (ISH)
Fluorescein isothiocyanate (FITC)-conjugated
Epstein-Barr encoded RNA (EBERs) oligonucleotides
were used as probes for the hybridization procedure
on paraffin sections. EBERs ISH was performed as
previously described by Preciado et al.10 Detection
of the hybridized sites was achieved using a mono-
clonal antibody anti-FITC labelled with alkaline
phosphatase (Novocastra, Newcastle-upon-Tyne,
UK), performed according to the manufacturer’s
instructions.
Polymerase chain reaction assay for
Mycobacterium tuberculosis
Preparation of DNA: Samples submitted were spu-
tum, CSF and blood. Sputum was decontaminated
and digested by the NALC-NaOH method.11 CSF was
concentrated by centrifugation. Both samples were
then treated with proteinase K. Peripheral blood
mononuclear cells were separated and DNA was
obtained.
PCR: Amplification of DNA was designed as
nested-PCR using the oligonucleotides described
by Eisenach and Nolte as primers IS-1 (884—865),
IS-2 (568—588) and IS-3 (762—781).12,13 Primer IS-4
(910—891) was personally selected from the com-
plete sequence published by Eisenach. The ampli-
fied region (123 bp) belongs to the IS6110 repeated
sequence which is specific forMycobacterium tuber-
culosis complex (M. tuberculosis, M. bovis, M. afri-
canum and M. microti).11,12 Both PCRs were
performed in a final volume of 50 ml containing
1.5 mM MgCl2; 200 mM (each) dNTPs; 0.5 mM (each)
primers; 1.25 U of Taq DNA polymerase; 1 PCR
buffer provided with the enzyme, and 5 ml of DNA
or 20 ml of lysis supernatant. The reaction was made
in a touchdown system from 70 8C to 68 8C for the
first round (IS-2-IS-4) and 74 8C to 68 8C for the
second (IS-1-IS-3). Inhibition was also evaluated.
The following biochemical characteristics were
used to identify M. bovis-BCG: negative niacin test;
98 A. Fallo et al.absence of nitrate reductase; susceptibility to thio-
phene-2-carboxylic acid; and resistance to pyrazi-
namide and cycloserine.Case report
A 30-month-old girl with AIDS was admitted to the
Hospital de Nin˜os ‘Ricardo Gutie´rrez’ in Buenos
Aires due to diarrhea and dehydration. Perina-
tally-acquired HIV infection was diagnosed at three
months of age. Her clinical history included Pneu-
mocystis carinii pneumonia, recurrent oral candi-
diasis, chronic diarrhea and bacterial pneumonia.
By 12 months of age she had neurodevelopmental
delay, hyperreflexia and a CT scan showed cerebral
atrophy. She had received BCG vaccine in her first
month of life. She was treated with different anti-
retroviral protocols because of clinical, immunolo-
gical and virological progression. A month prior to
admission she had been studied because fever and a
chest X-ray showed persistent atelectasia of the
right upper lobe and mild diffuse interstitial pul-
monary infiltrates without respiratory impairment.
Twenty units of PPD administered intradermally was
negative.Mycobacterium tuberculosis complex DNA
was detected by PCR in the blood, and therapy was
started with isoniazid, ethambutol, pyrazinamide
and amikacin.
She had no known exposure to adults with tuber-
culosis. Multiple studies failed to demonstrate TB in
her household contacts.
On admission she had diarrhea, fever and severe
dehydration, oral thrush, mild hepatosplenomegaly
and weight loss; her growth and development were
delayed, she was alert and hermental status was not
affected. She was on PCP prophylaxis with trimetho-
prim/sulphamethoxazole and antiretroviral therapy
with stavudine, nevirapine and ritonavir. Her viral
load was 5.8 log copies/ml, her CD4 was 1%
(16 cells/mm3) and CD8: 7% (112 cells/mm3).
Laboratory studies revealed a WBC of 2.8  109/L
with 66% neutrophils, 26% lymphocytes, 5% mono-
cytes and 3% eosinophils. Hemoglobin was 7.5 g/dl,
platelets were 6.9  109/L and the erythrocyte
sedimentation rate was raised (75 mm/h). Serum
chemistry was normal.
Microsporidia diarrhea and urinary tract infection
by Klebsiella pneumoniae were diagnosed and she
required parenteral hydration and antibiotics.
A behavioral change was noticed with features of
increasing apathy and decreasing willingness to
speak, to walk or to eat at ten days after admission.
On the 20th hospital day a left pretibial lesion was
observed. Radiographic examination showed an
osteolytic lesion of the tibia and multiple osteolyticlesions in the long bones of the extremities. A 99m
TC methylenediphosphonic acid bone scan demon-
strated increased uptake in multiple bones including
upper and lower extremities and skull, at the blood
pooling and late phases, compatible with osteomye-
litis.
The tibial lesion was surgically drained. Histo-
pathological examination of the bone revealed
tuberculous osteomyelitits. In the smear of biopsy
material over ten acid-fast bacilli per high power
field were seen. Rifampin and clarithromycin were
added to the previous scheme to give coverage for
Mycobacterium tuberculosis, BCG bacillus and
Mycobacterium avium-intracellulare complex.
Bone cultures for bacteria or fungi were negative.
Acid-fast stains of three separate samples of gastric
fluid and sputum collected on different days were
negative. PCR for the same samples was negative for
Mycobacterium tuberculosis complex. Abdominal
ultrasound examination showed only mild hepato-
megaly.
A CT scan was performed, showing mild diffuse
cortical atrophy. A high density lesion in the right
internal capsule, a left-sided lesion that caused
compression of the frontal horn and lateral ventricle
with surrounding edema, and high density lesions in
the basal ganglia, were seen (Figure 1). A presump-
tive diagnosis of CNS tuberculosis was made. CSF
examination was normal, the protein value was
27 g/dl and the glucose level 42 g/dl. No cells were
seen. Gram and Ziehl-Nielsen staining were nega-
tive. PCR TB was negative. CSF and blood cultures
were negative for bacteria, fungi andmycobacteria.
The test for cryptococcal antigen was negative and
serology for Toxoplasma gondii was also negative. A
bone marrow aspirate disclosed no pathologic find-
ings and culture was negative. Despite therapy
there was no improvement during the following
weeks.
The clinical condition worsened, with severe
insomnia and extreme irritability. She experienced
generalized seizures, nystagmus, compromize of
her mental status, myoclonic jerking, hypertonia
and hyperreflexia of all four limbs and neurogenic
respiratory depression requiring respiratory assis-
tance. Electroencephalography revealed diffuse
slowing, but epileptiform activity was not detected.
Funduscopic examination revealed no abnormal-
ities.
Repeated CSF examination showed only a mild
increase in protein level (67 g/dl). No cells were
seen. A new CT scan revealed diffuse cortical atro-
phy with enlarged ventricles and decrease of lesion
size in basal ganglia, with an enhanced diffuse zone
in the right frontal lobe and in both occipital lobes.
There were also low-density lesions in the internal
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Figure 1 Initial CT scan showing a small rounded hyperdense lesion surrounded by a low density zone (edema) that
causes compression of the left frontal horn and a high density lesion in the basal ganglia. Mild diffuse cortical atrophy is
seen.capsule and in the anterior corpus callosum
(Figure 2).
Differential diagnoses included disseminated
tuberculosis, primary HIVencephalopathy, toxoplas-Figure 2 Last CT scan showing diffuse cortical atrophy wit
ganglia. Enhanced diffuse zone in both occipital lobes. Hypod
subinsular region, without mass effect.mosis, CNS lymphoma or CNS fungal infection. A
cerebral biopsy was planned but could not be done
because the patient’s clinical condition worsened.
She died on the 71st hospital day.h enlarged ventricles and decreased lesion size in basal
ense lesion in the right posterior internal capsule and left
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Figure 3 Photomicrograph of brain specimen showing angiocentric distribution of atypical small lymphocytes with
angulated or cleaved nuclei (hematoxylin and eosin 250).Post-mortem examination revealed a diffuse CNS
lesion that involved brain parenchyma and bilateral
ventricles, with multiple cystic lesions in the tem-
poral lobules and a nodular lesion in the basal gang-
lia area. Histological examination disclosed atypical
lymphoid cells with a predominant perivascular
arrangement that involved cerebellum, brain stem
and spinal cord (Figure 3). Large foci of ischaemic
necrosis with calcifications and large intraparench-Figure 4 Immunohistochemical studies revealing aymatous and intraventricular haemorrhage were
found. No microorganisms were detected with PAS
and Ziehl-Nielsen staining. Immunohistochemically,
expressed B-cell antigen (CD20) and CD3, CD15,
CD30, CD68 were negative. These results showed
the diagnosis of this tumor to be a primary CNS
diffuse large B cell lymphoma (Figure 4).
The enlarged spleen showed small multiple
nodules which histologically were granulomatouspredominant B-cell population (CD 20) (400).
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Figure 5 EBER ISH showing nuclear labelling of tumor cells in central nervous system infiltrated with a diffuse large B
cell lymphoma (10).lesions without necrosis, with abundant intracellu-
lar acid-fast bacilli. Similar lesions were found in
mesenteric lymph nodes. Examination of the lung
revealed interstitial pneumonitis. BCG was cultured
from the tibial lesion.
EBV results
EBERs in situ hybridization (ISH) showed intense
nuclear labelling tending to spare the nucleolus.
LMP-1 positive staining was detected in tumor cells
localized to the cell membrane and cytoplasm
(Figure 5).Discussion
This case showed a co-infection with three aggres-
sive pathogens in one patient. The primary HIV
infection, which progressed to AIDS, and a second-
ary infection of a disseminated BCG infection with
the occurrence of an EBV-associated CNS lymphoma.
This case emphasizes the need for invasive diag-
nostic methods to disclose concomitant etiologies.
In this particular case, a brain biopsy could not be
carried out because of the deep location of the
lesion and the critical clinical status of the patient.
Only post-mortem examination revealed the final
diagnosis.
Disseminated BCG infection is a long-known
entity with numerous reports published prior to
the AIDS era, especially from European countries.A French national retrospective study reported 0.59
cases of disseminated BCG infection/1 million vac-
cinated healthy children.14
Lotte reported 2 cases/1 million with a mortality
rate of 80%, in a retrospective study from six Eur-
opean countries.15 Cellular immunodeficiency was
identified as the chief risk factor for fatal out-
come.15,16 Tuberculous osteitis is one of the most
frequent complications of the BCG vaccination.17,18
In severe immunodeficiency, there is a lack of
granuloma formation and unimpeded proliferation
of acid-fast bacilli and variable or absent necro-
sis.19,20 Usually these patients have specific unre-
sponsiveness to tuberculin tests.21 The case here
showed both histopathological findings, as there was
necrosis in the osteal lesion, but it was absent in the
spleen.
PCR led to the diagnosis of disseminated Myco-
bacterium tuberculosis complex infection one
month before the beginning of bone symptoms in
the reported patient. The sensitivity, specificity and
positive predictive value of PCR when applied to
pediatric samples for diagnosing tuberculosis are
78.4%, 96% and 97% respectively,22 and no cross
reaction with mycobacteria other than M. tubercu-
losis complex has been observed.23,24
In spite of some studies that report a small risk of
complications following BCG vaccination among HIV-
1 infected children and encouraged the benefits of
BCG vaccination,25,26 there are several reports
of severe, including fatal, disseminated BCG infec-
tion occurring in immunodeficient patients.9,27
102 A. Fallo et al.Therefore, BCG immunization programmes should
be reconsidered for children at risk of HIV infection.
Immunocompromized patients with late-stage AIDS
are at great risk, with an overall 71% mortality
reported.6,28 Both this case, and similar cases
reported, emphasize the hazards of BCG vaccination
in HIV-infected infants.
This is the first case of primary CNS lymphoma
seen at the Hospital de Nin˜os Ricardo Gutie´rrez in
Buenos Aires, Argentina, among 351 HIV-infected
children followed up prospectively.29 This repre-
sents a frequency lower than 1%, which is similar
to the 1996 CDC report of 30 children with CNS
lymphoma, among 7629 children with AIDS, which
represented a frequency of 0.4%. In addition, the
AIDS-Cancer Match Registry (July 2000) reported a
frequency of 0.5%.30,31 Only a few cases of primary
central nervous system NHL (non-Hodgkin’s lym-
phoma) occurring in children with HIV infection have
been reported so far.2—5 Other CNS NHL associated
with EBV have not yet been reported in Argentina.
The Epstein-Barr virus may be responsible for the
lymphoproliferative disorders described in HIV
infected children.32,33 When EBV infects B-lympho-
cytes, it induces cell proliferation. Such lymphopro-
liferative action may enable oncogenesis by
increasing the probability of genetic alterations
(e.g. chromosomal translocations such as those seen
in Burkitt lymphoma) and/or by expanding an
already malignant clone.7 Expression of LMP-1, an
oncogenic protein, by tumor cells supports the
involvement of EBV in disease pathogenesis. It is
well known that primary CNS lymphoma occurs with
increased frequency in adult patients with AIDS and
they are nearly always EBV positive.34
Like the case reported here, most patients died
very soon after the time of onset of symptoms
related to the lymphoma, suggesting the need of
both rapid diagnostic procedures and treatment.
Although the clinical outcome with current treat-
ments remains rather discouraging, there have been
some recent reports describing a more positive
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